Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example
<p>Abstract</p> <p>Background</p> <p>Schizophrenia is a severe, chronic, and costly illness that adversely impacts patients' lives and health care payer budgets. Cost comparisons of treatment regimens are, therefore, important to health care payers and researchers....
Main Authors: | Nyhuis Allen W, Faries Douglas E, Ascher-Svanum Haya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-05-01
|
Series: | Cost Effectiveness and Resource Allocation |
Online Access: | http://www.resource-allocation.com/content/7/1/11 |
Similar Items
-
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
by: Nyhuis Allen W, et al.
Published: (2009-09-01) -
Predictors of switching antipsychotic medications in the treatment of schizophrenia
by: Stauffer Virginia L, et al.
Published: (2010-09-01) -
Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia
by: Faries Douglas E, et al.
Published: (2010-01-01) -
Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
by: Xiaomei Peng, et al.
Published: (2011-01-01) -
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
by: Correll Christoph U, et al.
Published: (2008-04-01)